Alkem Laboratories Limited

Alkem Laboratories Limited (India) holds 45 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 4 FDA-registered manufacturing sites. 17 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Alkem Laboratories Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/alkem-laboratories-limited

Overview

Alkem Laboratories Limited is a leading Indian pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products. It offers a broad range of generic medications and is also involved in the production of active pharmaceutical ingredients (APIs).

Core services & business areas

Pharmaceutical ManufacturingRegulatory AffairsResearch and Development

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Alkem Laboratories Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Alkem Laboratories Limited holds 45 active (47 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • OLANZAPINEActive2026-03-31
  • TICAGRELORActive2025-10-17
  • ESLICARBAZEPINE ACETATEActive2025-01-06
  • QUETIAPINE FUMARATE USPActive2024-09-27
  • EZETIMIBE USPActive2024-05-22
  • LURASIDONE HYDROCHLORIDEActive2024-03-27
  • NEBIVOLOL HYDROCHLORIDEActive2024-03-15
  • AZILSARTAN KAMEDOXOMILActive2023-09-12
  • BEMPEDOIC ACIDActive2023-08-31
  • LISDEXAMFETAMINE DIMESYLATEActive2023-08-03
  • ESKETAMINE HYDROCHLORIDEActive2022-09-26
  • SOLRIAMFETOL HYDROCHLORIDEActive2022-03-28
  • CANNABIDIOLActive2022-02-08
  • RITALINIC ACIDActive2021-12-21
  • BIS-BOC-LISDEXAMFETAMINEActive2021-10-25
  • AMLODIPINE BENZOATEActive2021-03-31
  • LANTHANUM CARBONATE OCTAHYDRATEActive2020-10-21
  • MESALAMINE USPActive2019-07-06
  • ELUXADOLINEActive2019-01-02
  • DEXMETHYLPHENIDATE HYDROCHLORIDEActive2018-06-23
  • TOLVAPTANActive2017-10-06
  • APREMILASTActive2017-10-03
  • TAPENTADOL HYDROCHLORIDEActive2017-03-27
  • N-PHENYL-1-(2-PHENYLETHYL)-4-PIPERIDINAMINEActive2017-03-20
  • TOLTERODINE TARTRATE USPActive2016-09-30
  • CANAGLIFLOZINActive2016-09-16
  • ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USPActive2016-08-17
  • METHYLPHENIDATE HYDROCHLORIDE USPActive2016-07-29
  • DIMETHYL FUMARATEActive2016-07-26
  • AMLODIPINE BESYLATE USPActive2015-09-28
  • ESOMEPRAZOLE MAGNESIUM DIHYDRATEActive2014-10-01
  • SODIUM OXYBATEActive2014-06-19
  • DABIGATRAN ETEXILATE MESYLATEActive2014-05-27
  • MED-300179/E (INTERMEDIATE)Active2014-04-16
  • ARIPIPRAZOLE USPActive2014-02-13
  • DALFAMPRIDINE USPActive2013-11-01
  • RABEPRAZOLE SODIUM USPActive2013-09-01
  • DRONEDARONE HYDROCHLORIDEActive2013-03-26
  • TAPENTADOL HYDROCHLORIDEActive2012-10-23
  • RILUZOLE USPActive2011-09-24
  • LANSOPRAZOLE USPActive2011-07-29
  • RIZATRIPTAN BENZOATE USPActive2011-05-06
  • DULOXETINE HYDROCHLORIDEActive2011-03-17
  • RASAGILINE MESYLATEActive2010-04-26
  • HYDROUS BENZOYL PEROXIDE, USPActive2001-12-03
  • OLANZAPINE USPInactive2010-08-23
  • LAMOTRIGINEInactive2008-03-20

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to Alkem Laboratories Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

17 FDA enforcement records linked to this company.

  • 4832019-05-17

    Procedure Deviations Recorded and Justified

  • 4832019-05-17

    Acceptance of in-process materials

  • 4832019-05-17

    Approve or reject components, products

  • 4832019-05-17

    Procedures not in writing, fully followed

  • 4832018-03-27

    Written program not followed

  • 4832018-03-27

    Training , Education , Experience overall

  • 4832018-03-27

    Lack of quality control unit

  • 4832018-03-27

    Failing to test for penicillin cross-contamination

  • 4832018-03-27

    Cleaning / Sanitizing / Maintenance

  • 4832018-03-27

    Sanitation--buildings not clean, free of infestation

  • 4832018-03-27

    Approve or reject components, products

  • 4832018-03-27

    Complete test data included in records

  • 4832018-03-27

    Following/documenting laboratory controls

  • 4832018-03-27

    Scientifically sound laboratory controls

  • 4832018-03-27

    Identification of containers, lines, equipment

  • 4832018-03-27

    Procedures not in writing, fully followed

  • 4832018-03-27

    Tablet or capsule weight variation

For suppliers

Is this Alkem Laboratories Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.